A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)

PHASE3CompletedINTERVENTIONAL
Enrollment

499

Participants

Timeline

Start Date

August 22, 2013

Primary Completion Date

September 22, 2015

Study Completion Date

August 18, 2022

Conditions
Infection, Human Immunodeficiency VirusHIV Infections
Interventions
DRUG

Dolutegravir/abacavir/lamivudine FDC

Dolutegravir/abacavir/lamivudine FDC tablets, 50 mg/600 mg/300 mg

DRUG

Atazanavir

Atazanavir capsule 300 mg

DRUG

Ritonavir

Ritonavir tablet 100 mg

DRUG

Tenofovir/emtricitabine FDC

Tenofovir/emtricitabine FDC tablet 300 mg/200 mg of FTC

Trial Locations (90)

122

GSK Investigational Site, Mamelodi East

1141

GSK Investigational Site, Buenos Aires

1150

GSK Investigational Site, Lisbon

7754

GSK Investigational Site, Neptune City

7925

GSK Investigational Site, Observatory, Cape Town

10149

GSK Investigational Site, Turin

10330

GSK Investigational Site, Bangkok

10595

GSK Investigational Site, Valhalla

11000

GSK Investigational Site, Nonthaburi

14000

GSK Investigational Site, México

14215

GSK Investigational Site, Buffalo

16128

GSK Investigational Site, Genoa

18012

GSK Investigational Site, Granada

18102

GSK Investigational Site, Allentown

19104

GSK Investigational Site, Philadelphia

19107

GSK Investigational Site, Philadelphia

19140

GSK Investigational Site, Philadelphia

20007

GSK Investigational Site, Washington D.C.

20127

GSK Investigational Site, Milan

20157

GSK Investigational Site, Milan

21052

GSK Investigational Site, Busto Arsizio (VA)

24127

GSK Investigational Site, Bergamo

24501

GSK Investigational Site, Lynchburg

25123

GSK Investigational Site, Brescia

27514

GSK Investigational Site, Chapel Hill

28034

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

28207

GSK Investigational Site, Charlotte

28935

GSK Investigational Site, (Móstoles) Madrid

29010

GSK Investigational Site, Málaga

30003

GSK Investigational Site, Murcia

30033

GSK Investigational Site, Decatur

30309

GSK Investigational Site, Atlanta

31401

GSK Investigational Site, Savannah

32803

GSK Investigational Site, Orlando

33133

GSK Investigational Site, Miami

33401

GSK Investigational Site, West Palm Beach

33602

GSK Investigational Site, Tampa

34982

GSK Investigational Site, Ft. Pierce

41013

GSK Investigational Site, Seville

44093

GSK Investigational Site, Nantes

44280

GSK Investigational Site, Guadalajara

46202

GSK Investigational Site, Indianapolis

48202

GSK Investigational Site, Detroit

63110

GSK Investigational Site, St Louis

64111

GSK Investigational Site, Kansas City

68198

GSK Investigational Site, Omaha

75235

GSK Investigational Site, Dallas

75246

GSK Investigational Site, Dallas

75475

GSK Investigational Site, Paris

76104

GSK Investigational Site, Fort Worth

77401

GSK Investigational Site, Bellaire

79905

GSK Investigational Site, El Paso

85015

GSK Investigational Site, Phoenix

89106

GSK Investigational Site, Las Vegas

90211

GSK Investigational Site, Beverly Hills

93009

GSK Investigational Site, Bobigny

93301

GSK Investigational Site, Bakersfield

115035

GSK Investigational Site, Moscow

190103

GSK Investigational Site, Saint Petersburg

196645

GSK Investigational Site, Saint Petersburg

214006

GSK Investigational Site, Smolensk

302040

GSK Investigational Site, Oryol

445846

GSK Investigational Site, Toliyatti

30912-3130

GSK Investigational Site, Augusta

01199

GSK Investigational Site, Springfield

07103

GSK Investigational Site, Newark

27401-1209

GSK Investigational Site, Greensboro

C1405CKC

GSK Investigational Site, Ciudad Autónoma de Buenos Aires

C1202ABB

GSK Investigational Site, Ciudad de Buenos Aires

V6Z 1Y6

GSK Investigational Site, Vancouver

K1H 8L6

GSK Investigational Site, Ottawa

M4N 3M5

GSK Investigational Site, Toronto

M5G 2N2

GSK Investigational Site, Toronto

H2X 2P4

GSK Investigational Site, Montreal

2720-276

GSK Investigational Site, Amadora

4200-319

GSK Investigational Site, Porto

00717

GSK Investigational Site, Ponce

00936

GSK Investigational Site, Rio Piedras

00909

GSK Investigational Site, San Juan

03010

GSK Investigational Site, Alicante

08916

GSK Investigational Site, Badalona

08035

GSK Investigational Site, Barcelona

08907

GSK Investigational Site, Barcelona

B9 5SS

GSK Investigational Site, Birmingham

E1 1BB

GSK Investigational Site, London

NW3 2QG

GSK Investigational Site, London

W2 1NY

GSK Investigational Site, London

S10 2JF

GSK Investigational Site, Sheffield

SW17 0QT

GSK Investigational Site, Tooting, London

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY

NCT01910402 - A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA) | Biotech Hunter | Biotech Hunter